{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:52Z","timestamp":1793314792347,"version":"4.5.0"},"reference-count":45,"publisher":"BMJ","issue":"8","license":[{"start":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T00:00:00Z","timestamp":1644537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"DFG","award":["Gr 970\/9-1"],"award-info":[{"award-number":["Gr 970\/9-1"]}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA 16125"],"award-info":[{"award-number":["CA 16125"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Respiratory Society Clinical Research Collaboration","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"FP7 Coordination of Non\u2010Community Research Programme","award":["Gr FP7\u2010305653\u2010chILD\u2010EU"],"award-info":[{"award-number":["Gr FP7\u2010305653\u2010chILD\u2010EU"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>No data on healthcare utilisation and associated costs for the many rare entities of children\u2019s interstitial lung diseases (chILD) exist. This paper portrays healthcare utilisation structures among individuals with chILD, provides a pan-European estimate of a 3-month interval per-capita costs and delineates crucial cost drivers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Based on longitudinal healthcare resource utilisation pattern of 445 children included in the Kids Lung Register diagnosed with chILD across 10 European countries, we delineated direct medical and non-medical costs of care per 3-month interval. Country-specific utilisation patterns were assessed with a children-tailored modification of the validated FIMA questionnaire and valued by German unit costs. Costs of care and their drivers were subsequently identified via gamma-distributed generalised linear regression models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>During the 3 months prior to inclusion into the registry (baseline), the rate of hospital admissions and inpatient days was high. Unadjusted direct medical per capita costs (\u20ac19 818) exceeded indirect (\u20ac1 907) and direct non-medical costs (\u20ac1 125) by far. Country-specific total costs ranged from \u20ac8 713 in Italy to \u20ac28 788 in Poland. Highest expenses were caused by the disease categories \u2018diffuse parenchymal lung disease (DPLD)-diffuse developmental disorders\u2019 (\u20ac45 536) and \u2018DPLD-unclear in the non-neonate\u2019 (\u20ac47 011). During a follow-up time of up to 5 years, direct medical costs dropped, whereas indirect costs and non-medical costs remained stable.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This is the first prospective, longitudinal study analysing healthcare resource utilisation and costs for chILD across different European countries. Our results indicate that chILD is associated with high utilisation of healthcare services, placing a substantial economic burden on health systems.<\/jats:p><\/jats:sec>","DOI":"10.1136\/thoraxjnl-2021-217751","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T18:20:32Z","timestamp":1644603632000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Healthcare resource utilisation and medical costs for children with interstitial lung diseases (chILD) in Europe"],"prefix":"10.1136","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-3756","authenticated-orcid":false,"given":"Elias","family":"Seidl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5496-7749","authenticated-orcid":false,"given":"Nicolaus","family":"Schwerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-864X","authenticated-orcid":false,"given":"Julia","family":"Carlens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1462-9569","authenticated-orcid":false,"given":"Martin","family":"Wetzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-251X","authenticated-orcid":false,"given":"Steve","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1405-8401","authenticated-orcid":false,"given":"Nagehan","family":"Emiralio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1261-7393","authenticated-orcid":false,"given":"Nural","family":"Kiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4165-6455","authenticated-orcid":false,"given":"Joanna","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-784X","authenticated-orcid":false,"given":"Katarzyna","family":"Krenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-5690","authenticated-orcid":false,"given":"Nicola","family":"Ullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0937-2121","authenticated-orcid":false,"given":"Dora","family":"Krikovszky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the chILD-EU collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3301-3874","authenticated-orcid":false,"given":"Phillen","family":"Maqhuzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4650-7806","authenticated-orcid":false,"given":"Charlotte A","family":"Griese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9402-7700","authenticated-orcid":false,"given":"Larissa","family":"Schwarzkopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0113-912X","authenticated-orcid":false,"given":"Matthias","family":"Griese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,2,11]]},"reference":[{"key":"2023100203001967000_77.8.781.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201305-0923ST"},{"key":"2023100203001967000_77.8.781.2","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0100-2017","article-title":"Chronic interstitial lung disease in children","volume":"27","author":"Griese","year":"2018","journal-title":"Eur Respir Rev"},{"key":"2023100203001967000_77.8.781.3","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.10125"},{"key":"2023100203001967000_77.8.781.4","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-4-26"},{"key":"2023100203001967000_77.8.781.5","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2466-8-24"},{"key":"2023100203001967000_77.8.781.6","doi-asserted-by":"crossref","unstructured":"Torrent-Vernetta A , Gaboli M , Castillo-Corull\u00f3n S . Incidence and Prevalence of Children\u2019s Diffuse Lung Disease in Spain. Archivos de Bronconeumolog\u00eda 2021;3.doi:10.1016\/j.arbres.2021.06.001","DOI":"10.1016\/j.arbres.2021.06.001"},{"key":"2023100203001967000_77.8.781.7","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213217"},{"key":"2023100203001967000_77.8.781.8","doi-asserted-by":"crossref","DOI":"10.1186\/s13023-015-0339-1","article-title":"Categorizing diffuse parenchymal lung disease in children","volume":"10","author":"Griese","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"2023100203001967000_77.8.781.9","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23168"},{"key":"2023100203001967000_77.8.781.10","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-5-22"},{"key":"2023100203001967000_77.8.781.11","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00139508"},{"key":"2023100203001967000_77.8.781.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7245.1335"},{"key":"2023100203001967000_77.8.781.13","doi-asserted-by":"publisher","DOI":"10.1136\/ip.6.3.177"},{"key":"2023100203001967000_77.8.781.14","first-page":"39","article-title":"Cost-Of-Illness studies\u2014a primer","volume":"1","author":"Segel","year":"2006","journal-title":"RTI-UNC Center of Excellence in Health Promotion Economics"},{"key":"2023100203001967000_77.8.781.15","doi-asserted-by":"publisher","DOI":"10.2165\/11588380-000000000-00000"},{"key":"2023100203001967000_77.8.781.16","unstructured":"Luce BR , Elixhauser A . Standards for the socioeconomic evaluation of health care services. Springer Science & Business Media, 2012."},{"key":"2023100203001967000_77.8.781.17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.healthpol.2014.12.016","article-title":"Socio-Economic burden of rare diseases: a systematic review of cost of illness evidence","volume":"119","author":"Angelis","year":"2015","journal-title":"Health Policy"},{"key":"2023100203001967000_77.8.781.18","doi-asserted-by":"crossref","unstructured":"Linertov\u00e1 R , Garc\u00eda-P\u00e9rez L , Gorostiza I . Cost-of-illness in rare diseases. In: Rare diseases epidemiology: update and overview. Springer, 2017: 283\u201397.","DOI":"10.1007\/978-3-319-67144-4_17"},{"key":"2023100203001967000_77.8.781.19","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210519"},{"key":"2023100203001967000_77.8.781.20","first-page":"46","article-title":"[FIMA--questionnaire for health-related resource use in an elderly population: development and pilot study]","volume":"77","author":"Seidl","year":"2015","journal-title":"Gesundheitswesen"},{"key":"2023100203001967000_77.8.781.21","first-page":"66","article-title":"[Validation of the FIMA Questionnaire for Health-Related Resource Use Against Medical Claims Data: The Role Played by Length of Recall Period]","volume":"83","author":"Seidl","year":"2021","journal-title":"Gesundheitswesen"},{"key":"2023100203001967000_77.8.781.22","first-page":"53","article-title":"[Calculation of standardised unit costs from a societal perspective for health economic evaluation]","volume":"77","author":"Bock","year":"2015","journal-title":"Gesundheitswesen"},{"key":"2023100203001967000_77.8.781.23","first-page":"138","article-title":"[Classification of drugs using the ATC system (Anatomic, Therapeutic, Chemical Classification) and the latest changes]","volume":"58","author":"Skrbo","year":"2004","journal-title":"Med Arh"},{"key":"2023100203001967000_77.8.781.24","unstructured":"IMPPG . International medical products price guide, 2021. Available: https:\/\/mshpriceguide.org\/en\/home\/ [Accessed 24 Feb 2021]."},{"key":"2023100203001967000_77.8.781.25","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-014-0652-8"},{"key":"2023100203001967000_77.8.781.26","doi-asserted-by":"crossref","first-page":"i89","DOI":"10.1136\/ard.2009.117150","article-title":"The value of productivity: human-capital versus friction-cost method","volume":"69 Suppl 1","author":"van den Hout","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2023100203001967000_77.8.781.27","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzr010"},{"key":"2023100203001967000_77.8.781.28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.28.082206.094100"},{"key":"2023100203001967000_77.8.781.29","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-12-1"},{"key":"2023100203001967000_77.8.781.30","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2015-207349"},{"key":"2023100203001967000_77.8.781.31","unstructured":"Indicators O , Hagv\u00edsar O . Health at a glance 2019: OECD indicators. Paris: OECD Publishing, 2019."},{"key":"2023100203001967000_77.8.781.32","unstructured":"Kringos DS , Boerma WG , Hutchinson A . Building primary care in a changing Europe. World Health Organization. Regional Office for Europe, 2015."},{"key":"2023100203001967000_77.8.781.33","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1164\/rccm.201508-1655OC","article-title":"Persistent tachypnea of infancy. usual and aberrant","volume":"193","author":"Rauch","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2023100203001967000_77.8.781.34","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23183"},{"key":"2023100203001967000_77.8.781.35","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-9-1"},{"key":"2023100203001967000_77.8.781.36","doi-asserted-by":"publisher","DOI":"10.3310\/hta5020"},{"key":"2023100203001967000_77.8.781.37","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3111\/13696990903245863","article-title":"Cost of illness associated with Niemann-Pick disease type C in the UK","volume":"12","author":"Imrie","year":"2009","journal-title":"J Med Econ"},{"key":"2023100203001967000_77.8.781.38","unstructured":"Orphanet . Prevalence of rare diseases: bibliographic data. Orphanet report series rare diseases collection. Orphanet Report Series: Rare Diseases Collection."},{"key":"2023100203001967000_77.8.781.39","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200321140-00002"},{"key":"2023100203001967000_77.8.781.40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.103.6.e72"},{"key":"2023100203001967000_77.8.781.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2010.04.031"},{"key":"2023100203001967000_77.8.781.42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s40273-019-00797-2","article-title":"The economic burden of cystic fibrosis in Germany from a payer perspective","volume":"37","author":"Frey","year":"2019","journal-title":"Pharmacoeconomics"},{"key":"2023100203001967000_77.8.781.43","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60565-0"},{"key":"2023100203001967000_77.8.781.44","doi-asserted-by":"publisher","DOI":"10.1016\/S1569-1993(03)00024-9"},{"key":"2023100203001967000_77.8.781.45","doi-asserted-by":"publisher","DOI":"10.2307\/3349801"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thoraxjnl-2021-217751","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T10:04:19Z","timestamp":1696241059000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thoraxjnl-2021-217751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,11]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2022,7,25]]},"published-print":{"date-parts":[[2022,8]]}},"alternative-id":["10.1136\/thoraxjnl-2021-217751"],"URL":"https:\/\/doi.org\/10.1136\/thoraxjnl-2021-217751","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,11]]}}}